Agreement Will Launch First Ever Exoskeleton Rehabilitation Programs, Distribution in Northern India
(Marlborough, MA/Kolkata, India) — Exoskeleton leader ReWalk Robotics announced today a new partnership with Saimed Innovations, a leading medical technologies provider, to distribute the ReWalk exoskeleton systems in Northern India. This agreement marks a milestone for exoskeleton technology and the spinal cord injury community, as ReWalk becomes the first company to provide the robotics devices in India.
Saimed Innovations staff have begun the training process with ReWalk, and will start more extensive clinical and technical service training in the coming weeks. The staff will begin working with eligible users in the rehabilitation setting in Q2 of this year.
“Expansion to India has been both a goal and priority for ReWalk, as we assess the global need for exoskeletons,” said Larry Jasinski, CEO of ReWalk Robotics. “This landmark partnership with Saimed Innovations will provide first-time access to this technology for the spinal cord injured community across India. We believe there is potential to help a great number of people in this key geography,” he added.
“This will be a miraculous technology for eligible users in India,” said Rishi Kapoor, Partner of Saimed Innovations. “We look forward to beginning this partnership with ReWalk.”
The distribution agreement expands the ReWalk footprint into a crucial market and economy; this partnership is another important step in ReWalk’s international growth, which also expanded distribution to Australia in late 2014. In addition, ReWalk has received regulatory clearances for their exoskeleton systems in several global geographies including: North America, Europe, Asia, the Middle East and Australia.
ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk. The system provides user-initiated mobility through the integration of a wearable brace support, a computer-based control system and motion sensors. The system allows independent, controlled walking while mimicking the natural gait patterns of the legs. ReWalk is the only exoskeleton system cleared by the FDA for both personal use as well as use in a rehabilitation setting in the United States.
Saimed is a professionally managed organization focused relentlessly on innovation in health care. The company’s present business areas include: cardiology, endovascular, neurological intervention, urology and clinical management, among many others. Since the firm’s inception Saimed is committed to providing state of the art innovative technologies and clinical management services to health care providers. The cumulative expertise and experience of more than 15 years in the global field of medical device management are the strong pillars of Saimed’s excellence.
ReWalk plans to launch its inaugural programs in India in Spring 2015, with distribution of systems already underway across Northern India.
About ReWalk Robotics
ReWalk Robotics (formerly Argo Medical Technologies) develops, manufactures and markets wearable robotic exoskeletons for people with lower limb disabilities, such as paraplegia. ReWalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. ReWalk is proud to offer the only FDA cleared exoskeleton systems in the United States, for rehab and personal use respectively. Founded in 2001, ReWalk Robotics is a global company with headquarters in the US, Germany, and Israel. For more information on ReWalk Robotics and the ReWalk Systems, please visit http://www.rewalk.com.
